Hinge Bio
PrivateLast Round
Series A
Jan 15, 2025
Est. Valuation
$46M
Total Funding Raised
$30M
Momentum
Top 50%
of companies Caplight tracks
Company Overview
Hinge Bio is a biotechnology company that develops multispecific antibody therapeutics for autoimmune diseases, inflammatory diseases, and cancer using its proprietary GEM-DIMER™ platform.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery
Business Model
B2B
Customer Profile
Services & Consulting, Revenue Share
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Hinge Bio Comparables
Compare Hinge Bio with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Candid Therapeutics | 79% | |
| Dren Bio | 78% | |
| Cullinan Oncology | 77% |
Hinge Bio Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series A | Jan 15, 2025 |
Key People
Founding team and executive leadership
Hinge Bio Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Thornapple River Capital | Series A |
| Ridgeback Capital | Series A |
| InVivium Capital | Series A |
| Point72 | Series A |
| Lightswitch Capital | Series A |
| Point72 Ventures | Series A |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jun 20, 2026
Monthly visitors increased 70% MoM.
- Oct 13, 2025
Regulatory milestone achieved for Lupus therapy, enabling clinical trials.
Hinge Bio Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Hinge Bio's valuation, stock price, and market status.
Is Hinge Bio a public or private company?
Hinge Bio is a private company.
What is the current stock price of Hinge Bio?
Hinge Bio is a private company with no public stock price. No recent secondary market data is available.
How much is Hinge Bio worth (valuation)?
Valuation information for Hinge Bio is not publicly available.
Can I buy Hinge Bio stock?
Hinge Bio shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was Hinge Bio's last funding round?
Hinge Bio's most recent funding round was Series A on January 15, 2025.
Who are the main investors in Hinge Bio?
Key investors in Hinge Bio include Point72, Point72 Ventures.
Will Hinge Bio IPO soon?
No public IPO plans have been announced for Hinge Bio.
How can I track Hinge Bio secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Hinge Bio's secondary market activity and sign up for updates.